Clinical Efficacy

Clinical Efficay

The Paxman Scalp Cooling System is the only FDA cleared scalp cooling system based upon a randomized clinical trial.

The Paxman Scalp Cooling system is globally recognized as the leading product for hair-loss prevention during chemotherapy treatment.

Having carried out extensive clinical trials and device refinement, we have created a system that is clinically proven, cost-effective and widely embraced by physicians, nurses and patients alike.

RANDOMIZED
US TRIAL

OUR GLOBAL
STUDIES

Extensive Global Experience:

Since 2003, more than 65 clinical studies have been conducted in more than 17 countries including: Australia, Austria, Canada, Denmark, France, Germany, Greece, India, Italy, Japan, Lebanon, Netherlands, Norway, Sweden, Switzerland, UK and the US.

Paxman Hub

100000

PATIENTS TREATED

Paxman Hub

40

AVAILABLE MARKETS

Paxman Hub

20

YEARS IN USE

Paxman Hub

65

STUDIES WORLDWIDE

Research and Development

We are leading the way in research to ensure a better understanding of scalp cooling. The more we know, the more we can guide the development of our system and cap, and the more effective a treatment scalp cooling can become.
Find out more about how we are chasing zero hair loss during chemotherapy at the Paxman Research & Innovation Centre, the first of its kind in the world.

DOWNLOAD OUR
CLINICAL EFFICACY
BROCHURE